Victory Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.9M | Sell |
385,463
-52,730
| -12% | -$3.68M | 0.02% | 775 |
|
|
2025
Q1 | $32.2M | Buy |
438,193
+34,123
| +8% | +$2.51M | 0.03% | 628 |
|
|
2024
Q4 | $26.5M | Buy |
404,070
+141,517
| +54% | +$9.27M | 0.03% | 730 |
|
|
2024
Q3 | $20.5M | Sell |
262,553
-1,898
| -0.7% | -$148K | 0.02% | 839 |
|
|
2024
Q2 | $20.6M | Sell |
264,451
-1,240
| -0.5% | -$96.7K | 0.02% | 802 |
|
|
2024
Q1 | $18M | Sell |
265,691
-9,427
| -3% | -$639K | 0.02% | 853 |
|
|
2023
Q4 | $18.5M | Buy |
275,118
+525
| +0.2% | +$35.4K | 0.02% | 806 |
|
|
2023
Q3 | $18.6M | Buy |
274,593
+51,687
| +23% | +$3.5M | 0.02% | 783 |
|
|
2023
Q2 | $16M | Sell |
222,906
-12,790
| -5% | -$915K | 0.02% | 860 |
|
|
2023
Q1 | $16.4M | Buy |
235,696
+36,313
| +18% | +$2.52M | 0.02% | 861 |
|
|
2022
Q4 | $13.5M | Sell |
199,383
-9,663
| -5% | -$655K | 0.02% | 922 |
|
|
2022
Q3 | $11.5M | Buy |
209,046
+34,569
| +20% | +$1.9M | 0.01% | 1022 |
|
|
2022
Q2 | $11.5M | Buy |
174,477
+1,418
| +0.8% | +$93.7K | 0.01% | 1018 |
|
|
2022
Q1 | $11.5M | Buy |
173,059
+92,808
| +116% | +$6.16M | 0.01% | 1068 |
|
|
2021
Q4 | $4.68M | Buy |
80,251
+40,087
| +100% | +$2.34M | ﹤0.01% | 1343 |
|
|
2021
Q3 | $2.41M | Sell |
40,164
-5,798
| -13% | -$348K | ﹤0.01% | 1545 |
|
|
2021
Q2 | $2.75M | Sell |
45,962
-14,619
| -24% | -$876K | ﹤0.01% | 1539 |
|
|
2021
Q1 | $3.01M | Buy |
60,581
+2,896
| +5% | +$144K | ﹤0.01% | 1521 |
|
|
2020
Q4 | $2.88M | Buy |
+57,685
| New | +$2.88M | ﹤0.01% | 1394 |
|
|
2019
Q3 | – | Sell |
-412,544
| Closed | -$17M | – | 3764 |
|
|
2019
Q2 | $17M | Buy |
412,544
+4,370
| +1% | +$180K | 0.03% | 656 |
|
|
2019
Q1 | $16.5M | Hold |
408,174
| – | – | 0.04% | 611 |
|
|
2018
Q4 | $15.5M | Buy |
+408,174
| New | +$15.5M | 0.04% | 618 |
|